Identification of MS-specific serum miRNAs in an international multicenter study

Conclusions These findings further confirm the use of circulating serum miRNAs as biomarkers to diagnose and monitor disease status in MS. Classification of evidence This study provides Class III evidence that levels of circulating miRNAs identify patients with MS.

http://nn.neurology.org/cgi/content/short/5/5/e491?rss=1

Source: Neurology Neuroimmunology and Neuroinflammation - August 20, 2018 Category: Neurology Authors: Regev, K., Healy, B. C., Paul, A., Diaz-Cruz, C., Mazzola, M. A., Raheja, R., Glanz, B. I., Kivisäkk, P., Chitnis, T., Jagodic, M., Piehl, F., Olsson, T., Khademi, M., Hauser, S., Oksenberg, J., Khoury, S. J., Weiner, H. L., Gandhi, R. Tags: Class III, Multiple sclerosis Article Source Type: research